Nanexa

Nanexa has developed the proprietary PharmaShell^® technology, using ALD nanocoatings to create ultra-long-acting depot formulations that aim to improve patient adherence and treatment outcomes through reduced dosing frequency.

Visit Website

Headquarters
Nanexa AB
Virdings Allé 2
SE-75450 Uppsala
Sweden

Phone / Contact

T: +46 18 100 300
E: [email protected]

Connect

Nanexa is a drug delivery company focused on long-acting injectables. It has developed the proprietary PharmaShell® technology, using ALD nanocoatings to create ultra-long-acting depot formulations. The company partners with global pharma firms to apply PharmaShell across various therapeutic areas, aiming to improve patient adherence and treatment outcomes through reduced dosing frequency.

Nanexa was founded in 2007. Its shares are listed on the Nasdaq First North Growth Market in Stockholm, Sweden (ticker symbol: NANEXA).